Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic myopathies.

R W Kuncl1, W W Wiggins

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Neurologic Clinics
|August 1, 1988
PubMed
Summary

Toxic myopathies are often missed. Understanding toxin mechanisms, risk factors, and clinical signs improves detection of these muscle disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2001
Same author

A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.

Arthritis and rheumatism·2001
Same author

Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons.

Neuroreport·2001
Same author

Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration.

Neurobiology of disease·1999
Same author

Occult presentation of myotonia congenita in a 15-year-old athlete.

The American journal of sports medicine·1999
Same author

Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration.

Journal of neuropathology and experimental neurology·1999

Area of Science:

  • Neurology
  • Toxicology
  • Muscle Diseases

Background:

  • Toxic myopathies are frequently underdiagnosed in clinical practice.
  • Limited understanding of the underlying mechanisms hinders accurate diagnosis.
  • Early recognition is crucial for effective patient management.

Purpose of the Study:

  • To elucidate the mechanisms of toxin-induced muscle damage.
  • To identify predisposing risk factors for toxic myopathy.
  • To describe key clinical syndromes associated with toxic myopathies.

Main Methods:

  • Review of existing literature on toxic myopathies.
  • Analysis of case studies and clinical data.
  • Synthesis of information on toxin-pathology relationships.

Main Results:

  • Detailed explanation of how various toxins affect muscle tissue.
  • Identification of patient populations and conditions increasing risk.
  • Characterization of distinct clinical presentations for specific toxins.

Conclusions:

  • Enhanced understanding of toxic myopathy mechanisms is essential.
  • Identifying risk factors aids in proactive screening and diagnosis.
  • Recognizing specific clinical syndromes improves diagnostic accuracy and patient outcomes.

Related Experiment Videos